Transl Clin Pharmacol.  2016 Sep;24(3):127-131. 10.12793/tcp.2016.24.3.127.

Rooibosâ„¢: Automated schedule broadcast software for clinical pharmacology studies

• Lee JH
• Chong WS
• Park JK
• Park TS
• Chae SW
• Kim MG

• KMID: 2351798
• DOI: http://doi.org/10.12793/tcp.2016.24.3.127

Abstract

Pharmacokinetic blood sampling is a prerequisite for successful early clinical trials. It is essential to take samples at the precise designated times to ensure the reliability of the clinical trial data; however, investigators have encountered difficulties in conducting procedures with limited manpower. We have recently developed automated schedule broadcast software (Rooibosâ„¢) to manage the precise scheduling of procedures for clinical trial centers. Rooibosâ„¢ is platform independent because it is programmed in the Java language. It generates scheduled times based on a reference time. It alarms at the scheduled times and pages subjects and alerts staff to prepare for the upcoming procedures. Rooibosâ„¢ can also group subjects when multiple clinical trials are conducted simultaneously in one or more clinical trial wards. This software may be applied to any study involving procedures that must be performed at designated times.

Keyword

Automated schedule; Clinical Trial; Pharmacokinetic; Pharmacodynamic; Software

MeSH Terms

Appointments and Schedules*
Humans
Indonesia
Pharmacology, Clinical*
Research Personnel

Figure

• 

  Figure 1. System Configuration.

• 

  Figure 2. Main window of Rooibos™.

• 

  Figure 3. Schematic representation of Rooibos™.

• 

  Figure 4. Rooibos™ algorithm.

• 

  Figure 5. Schedule setting example for one group.

• 

  Figure 6. Multi-group schema.

• 

  Figure 7. Group selection.

• 

  Figure 8. Schedule setting example for multiple groups.

• 

  Figure 9. Changing a reference time.

• 

  Figure 10. Disabling broadcast of a subject.

• 

  Figure 11. Broadcast action in text.

Reference

1.International Conference on Harmonisation. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice: E6. http://www.ich.org/fil-eadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf. Accessed July. 2015.

2.National Library of Medicine. Clinical Trials. https://medlineplus.gov/clini-caltrials.html. Accessed July. 2015.

3.Meibohm B., Derendorf H. Pharmacokinetic/pharmacodynamic studies in drug product development. J Pharm Sci. 2002. 91:18–31.

4.US Food and Drug Administration. Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product. 2014. 436–261. http://www.fda.gov/downloads/drugs/guidancecomplian-ceregulatoryinformation/guidances/ucm397017.pdf. Accessed July 2015.

5.Teuscher N. Using sampling “windows” for PK blood samples. http://learn-pkpd.com/2013/10/15/using-sampling-windows-for-pk-blood-samples/. Accessed Auguest. 2015.

6.Zuckerman AE. Using the Java language to develop computer based patient records for use on the Internet. Proc AMIA Annu Fall Symp. 1996. 772–776.

7.Choi HG., Jeon JY., Im YJ., Kim Y., Song EK., Seo YH, et al. Pharmacokinetic properties of two erlotinib 150 mg formulations with a genetic effect evaluation in healthy Korean subjects. Clin Drug Investig. 2015. 35:31–43. DOI: doi: 10.1007/s40261-014-0248-4.